Dr. Sanjeev Grewal, MD

Dr. Grewal practices at Acuity Eye Specialists in Palm Springs, California.

Dr. Grewal's NPI, 1972573103, was assigned on January 23, 2006. Dr. Grewal graduated from University of Toronto Faculty of Medicine in 1993. Dr. Grewal holds California license C136854.

Dr. Grewal's primary practice is Acuity Eye Specialists, at 1801 E Tahquitz Canyon Way, Palm Springs, CA 92262 in Riverside County. The practice phone is (760) 327-2700.

Dr. Grewal's primary practice is Acuity Eye Specialists in Palm Springs, California. Dmand AI also links Dr. Grewal to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Grewal practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Grewal's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Grewal is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Grewal's licenses on file in 6 states: California, District of Columbia, Maryland, Virginia, Pennsylvania and South Carolina.

Dmand AI lists cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Grewal treats.

CMS data shows 1,102 Medicare services from Dr. Grewal across 14 procedure codes in 2024, for 434 Medicare patients. Medicare paid $112,885 for them.

CMS counts 434 Medicare patients who saw Dr. Grewal in 2024. The largest group is 65 to 74, with 215 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Grewal's median patient age at 71, with 51% women.

In 2024, Dr. Grewal wrote 3,433 Medicare Part D claims for 991 patients. 60% of them were for generic drugs. CMS names the drug for 3,329 of them, across 21 drugs with 11 or more claims each, at $147,448 in total drug cost. In 2023, CMS named 4,418 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Grewal for performance year 2024, reported individually. Dr. Grewal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 84 procedures of cataract surgery by Dr. Grewal, more than 72% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Grewal in 2016. Dr. Grewal's most frequent co-authors are David Anthony Belyea, MD and Nisha Chadha, MD.

CMS Open Payments shows 35 general payments to Dr. Grewal from 11 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Alcon Laboratories Inc paid the most, $334.

Dmand AI lists 2 awards for Dr. Grewal, most recently Regional Top Doctor in 2014.

Dr. Grewal graduated from University of Toronto Faculty of Medicine in 1993. Dr. Grewal is a member of AAO.

Dr. Grewal is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.